Australia markets closed

Arcimoto, Inc. (FUV)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.71-0.18 (-3.06%)
At close: 04:00PM EST
5.70 -0.01 (-0.18%)
After hours: 07:24PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 215.06M
Enterprise value 186.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)49.58
Price/book (mrq)2.94
Enterprise value/revenue 44.23
Enterprise value/EBITDA -5.91

Trading information

Stock price history

Beta (5Y monthly) 2.30
52-week change 3-72.76%
S&P500 52-week change 317.11%
52-week high 336.80
52-week low 34.52
50-day moving average 38.57
200-day moving average 311.35

Share statistics

Avg vol (3-month) 3759.12k
Avg vol (10-day) 3974.46k
Shares outstanding 537.66M
Implied shares outstanding 6N/A
Float 829.26M
% held by insiders 123.55%
% held by institutions 124.62%
Shares short (13 Jan 2022) 49.8M
Short ratio (13 Jan 2022) 415.03
Short % of float (13 Jan 2022) 438.27%
Short % of shares outstanding (13 Jan 2022) 426.01%
Shares short (prior month 14 Dec 2021) 48.9M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin 0.00%
Operating margin (ttm)-824.01%

Management effectiveness

Return on assets (ttm)-38.17%
Return on equity (ttm)-61.10%

Income statement

Revenue (ttm)4.22M
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)119.10%
Gross profit (ttm)-6.07M
Net income avi to common (ttm)-30.68M
Diluted EPS (ttm)-0.86
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)32.98M
Total cash per share (mrq)0.88
Total debt (mrq)4.43M
Total debt/equity (mrq)5.88
Current ratio (mrq)7.37
Book value per share (mrq)2.01

Cash flow statement

Operating cash flow (ttm)-30.7M
Levered free cash flow (ttm)-35.17M